Pharmacotherapy for Hematologic Disorders
Pharmacotherapy for Hematologic Disorders In the 1970s, the average lifespan for patients diagnosed with sickle cell disease was 14 years. Today, the average lifespan has increased to 50 years and beyond (TriHealth, 2012). The patient prognosis for many other hematologic disorders such as hemophilia and cancer continue to improve as well. This can be attributed […]
Date: April 19th, 2022